Foundation stone laid for new building for biomedicine in Basel
Foundation stone laid for new €365 million building for biomedicine in Basel
Keystone-SDA
Select your language
Generated with artificial intelligence.
Listening: Foundation stone laid for new building for biomedicine in Basel
The foundation stone for the new Centre for Biomedicine building was laid on the University of Basel's Life Sciences Campus on Friday. The laboratory building, which will cost CHF365 million ($444 million), will host around 700 researchers from 2030/2031, the university announced on Friday.
This content was published on
3 minutes
Keystone-SDA
Deutsch
de
Grundsteinlegung für 365-Millionen-Neubau für Biomedizin in Basel
Original
According to the press release, the building will bring together all the units of the Department of Biomedicine, which were previously spread across several locations. It is ideally located in the immediate vicinity of the Biozentrum, the university hospitals and the Department of Biosystems Science and Engineering at the federal technology institute ETH Zurich.
“With its 11 floors and a height of more than 40 meters, it will be a powerful center for translational research, aiming to translate laboratory findings into medical treatments,” said the press release.
The new building project is being realised by Implenia as total contractor. This model guarantees the University of Basel a binding contract price and therefore a high level of cost certainty, writes the university.
Much more expensive than originally planned
With this model, the university aimed to avoid the new Biozentrum building debacle. Nevertheless, this new building will also be massively more expensive than originally planned – by CHF153 million.
More
More
US tariffs pressure Swiss pharma powerhouse
This content was published on
Looming US pharma tariffs could challenge the status quo in pharmaceutical hubs like Switzerland as investment shifts to the US.
This was accompanied by an increase in the loan guarantee from the two sponsoring cantons of Basel-City and Basel-Country from CHF106 million to CHF182.5 million. The two cantonal parliaments approved this equally divided guarantee amount in 2023.
The Department of Biomedicine at the University of Basel conducts research at the interface between basic science and medical application. The main areas of research range from cancer and immune research to regenerative medicine and neurosciences.
Adapted from German by DeepL/ac
We select the most relevant news for an international audience and use automatic translation tools to translate them into English. A journalist then reviews the translation for clarity and accuracy before publication.
Providing you with automatically translated news gives us the time to write more in-depth articles. The news stories we select have been written and carefully fact-checked by an external editorial team from news agencies such as Bloomberg or Keystone.
If you have any questions about how we work, write to us at english@swissinfo.ch
Popular Stories
More
Climate adaptation
Why Switzerland is among the ten fastest-warming countries in the world
Pilots’ union seeks to end deal with SWISS over working conditions
This content was published on
The Aeropers pilots’ union is expected to end its collective labour agreement with SWISS, as it pushes for better working conditions for its members.
Drugs often approved for wider use than tested, says Swiss study
This content was published on
A study by the University of Zurich, ETH Zurich and Yale and Harvard universities found that many medicines are approved for groups not tested in trials.
This content was published on
Over the four days, around 98,000 people – including volunteers – made their way up Bern’s local mountain for the 42nd edition of the festival.
Foreign residents in Moutier gain voting rights before town joins canton Jura
This content was published on
Foreign nationals living in Moutier will be able to vote in local and cantonal elections this year, even before the town joins the canton of Jura in 2026.
This content was published on
By 8am on Saturday, an 11-kilometre queue had formed at the Gotthard tunnel’s northern entrance, with drivers facing nearly two hours of delays.
Plant-based meat market in Switzerland set to grow to CHF361 million by 2030
This content was published on
Switzerland’s market for plant-based meat alternatives has a potential value of around CHF 242 million this year, though it remains a niche market.
This content was published on
The army is looking for a modern solution for its decommissioned fortress mortar bunkers, with plans to turn them into hardened defence hubs.
This content was published on
Spain ended Switzerland’s run in the Women’s Euros on Friday, but fans in Bern made history with the largest supporters’ march in Women’s Euros history.
This content was published on
Solar energy pioneer Raphaël Domjan and his team continued preparations for the altitude record attempt at 10,000 metres with the SolarStratos solar aircraft.
This content was published on
Cattle in the canton of Geneva and in the neighbouring region of Terre Sainte in the canton of Vaud are being vaccinated against the contagious viral skin nodule disease. The first cases of the animal disease were reported at the end of June in France, just outside Geneva.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.